Medtronic’s Kyphon Cement Cleared for Sacral Fracture

Medtronic gained FDA 510(k) clearance to market Kyphon™ HV-R Bone Cement for fixation of fractures of the sacral vertebral body using sacroplasty. This expands on earlier indications for treatment of vertebral compression fractures caused by osteoporosis, cancer or benign lesions.

In 1Q17, the company received FDA 510(k) clearance of...

document icon

You are out of free articles for this month

Subscribe as a Guest for $0 and unlock a total of 5 articles per month.

You are out of five articles for this month

Subscribe as an Executive Member for access to unlimited articles, THE ORTHOPAEDIC INDUSTRY ANNUAL REPORT and more.


Julie Vetalice is ORTHOWORLD's Editorial Assistant. She has covered the orthopedic industry for over 20 years, having joined the company in 1999.

Contact Us